Hepatitis B risks and immunization coverage among American travelers

Journal of Travel Medicine

Volumn 13, Issue 5, 2006, Pages 273-280

  Connor, Bradley A ^a,b   Jake Jacobs, R ^c   Meyerhoff, Allen S ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b New York Center for Travel and Tropical Medicine   (United States)

^c Capitol Outcomes Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; BLOOD; BODY FLUID; CAUCASIAN; CONSULTATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; EMPORIATRICS; ENDEMIC DISEASE; EXPOSURE; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HEPATITIS B; HOUSEHOLD; HUMAN; IMMUNIZATION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; TRAVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRAVEL; UNITED STATES; VACCINATION;

EID: 33748950644     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00055.x     Document Type: Article

References (25)

1. Steffen R. Risks of hepatitis B for travellers. Vaccine 1990; 8(Suppl):S31-S32.
2. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and the subsequent development of the carrier state. J Infect Dis 1985; 151:599-603.
3. Mahoney FJ, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd Ed. Philadelphia, WB Saunders Company, 1999:158-182.
4. Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002; 185:713-719.
5. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954.
6. Hauboldt RH. Cost implications of human organ and tissue transplantations, an update: 1999. Seattle: Milliman & Robertson Inc, 1999.
7. Kim WR, Poterucha JJ, Hermans JE, et al. Cost-effectiveness of 6 and 12 months of interferon therapy for chronic hepatitis C. Ann Intern Med 1997; 127:866-874.
8. Edmunds WJ, Medley GK, Nokes DJ, et al. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B Biol Sci 1993; 253:197-201.
9. Jacobs RJ, Saab S, Meyerhoff AS. The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health 2003; 51:227-236.
10. Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med 2004; 11:23-26.
11. Van Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med 2004; 11:3-8.
12. Zuckerman JN, Steffen R. Risks of hepatitis B in travelers as compared to immunization status. J Travel Med 2000; 7:170-174.
13. Fishbein DB, Willis DB, Cassidy WB, et al. Determining indications for adult vaccination: patient-assessment, medical record, or both? Vaccine 2006; 24:803-818.
14. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary, NC: SAS Institute Inc, 1995:172-175.
15. Bolton P, Holt E, Ross A, et al. Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep 1998; 113:521-526.
16. Peddecord KM, Linton LS, Edwards C, et al. Comparing telephone and written surveys to assess local adolescent immunization coverage rates. J Public Health Manag Pract 2004; 10:54-62.
17. Office of Travel and Tourism Industries, US Department of Commerce. 2004 profile of U.S. resident traveler visiting overseas destinations. Available at: http://tinet.ita.doc.gov/view/f_2004_101_001/index.html. (Accessed 2005 Oct 12)
18. Joines RW, Blatter M, Abraham B, et al. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine 2001; 19:4710-4719.
19. Coleman PJ, McQuillan GM, Moyer LA, et al. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998; 178:954-959.
20. Centers for Disease Control and Prevention. Hepatitis B vaccination - United States, 1982-2002. MMWR 2002; 51:549-552, 563.
21. Jacobs RJ, Meyerhoff AS. Effect of middle-school entry requirements on adolescent hepatitis B immunization. J Adolesc Health 2004; 34:420-423.
22. Vilella A, Bayas JM, Diaz MT, et al. The role of mobile phones in improving vaccination rates in travelers. Prev Med 2004; 38:503-509.
23. Jacobs RJ, Meyerhoff AS, Saab S. Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci 2005; 50:1525-1531.
24. Margolis HS, Handsfield HH, Jacobs RJ, Gangi J. Office-based intervention to improve vaccination status of patients at risk for sexual transmission of hepatitis B virus infection. Am J Obstet Gynecol 2000; 182:1-6.
25. Atkinson WL, Pickering LK, Schwartz B, et al. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR Recomm Rep 2002; 51(RR-2):1-35.